上海交通大學(xué)內(nèi)科學(xué)專業(yè)導(dǎo)師：吳凌云 正文

　　
　　?基本信息
　　導(dǎo)師姓名：吳凌云
　　性別：女
　　專業(yè)名稱：內(nèi)科學(xué)
　　專業(yè)代碼：100201
　　培養(yǎng)單位：附屬第六人民醫(yī)院
　　專業(yè)領(lǐng)域：血液病
　　導(dǎo)師類型：碩士生導(dǎo)師
　　郵箱地址：lincy2032@yahoo.com.cn

　　?研究方向
　　骨髓增生異常綜合征發(fā)病機(jī)制及診治

　　?社會任職
　　中華醫(yī)學(xué)會上海市血液學(xué)分會委員

　　?科研項目

　　?學(xué)術(shù)論文

作者	論文標(biāo)題	期刊名	出版年	卷期頁碼
張耀,宋陸茜,吳凌云 （通訊作者）,常春康,李曉	p15INK4B甲基化與骨髓增生異常綜合征患者預(yù)后及地西他濱療效的關(guān)系	中華血液學(xué)雜志	2013	34(3) :237-241
Zhang X, Chang C, Zhao Y, Wu L, Zhang Z, Li X.	The effect of the combination of bisphosphonates and conventional chemotherapy on bone metabolic markers in multiple myeloma patients.	Hematology	2012	17(5):255-60.
Wu L, Li X, Xu F, Chang C, He Q, Zhang Z, Zhang Y.	Over-expression of RPL23 in myelodysplastic syndromes is associated with apoptosis resistance of CD34(+) cells and predicts poor prognosis and distinct response to CHG chemotherapy or decitabine.	Ann Hematol.	2012	91 (10):1547-1554
Xu F, Wu L, He Q, Zhang Z, Chang C, Li X.	Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.	Intern Med J	2012	42(4):401-11.
Xu F, Yang R, Wu L, He Q, Zhang Z, Zhang Q, Yang Y, Guo J, Chang C, Li X.	Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome.	Cancer Lett.	2012	317(1):33-40
Xiao L, Qi Z, Qiusheng C, Li X, Luxi S, Lingyun W.	The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression.	Am J Hematol.	2012	87(1):26-31.
Yang Y, Zhang Q, Xu F, Wu L, He Q, Li X.	Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome.	J Cancer Res Clin Oncol.	2012	138(5):729-37
Zhang Y, Wu L （共同第一作者）, et al.	Low RPS14 gene expression is accompanied by p53-independent apoptosis in MDS patients with 5q- aberrations.	HealthMED	2012	6(7):2456-2463
Xu F, Li X, Wu L, Zhang Q, Yang R, Yang Y, Zhang Z, He Q, Chang C.	Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.	Ann Hematol.	2011	90(6):643-53
Wu L, Li X, Su J, He Q, Zhang X, Chang C, Pu Q.	Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS.	J Cancer Res Clin Oncol	2011	137(10):1563-9.
Zheng Z, Feng X, Xiao L, Qianqiao Z, Qi H, Lingyun W.	Removal of autologous activated CD4-positive T lymphocytes also results in increased colony-forming units in patients with low and intermediate-1 risk myelodysplastic syndromes.	Eur J Haematol.	2011	86(1):47-56.
Li X, Xu F, He Q, Wu L, Zhang Z, Chang C.	Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA).	Intern Med	2010	49(14):1349-55.
Xu F, Li X, Wu L, He Q, Zhang Z, Chang C.	Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.	Br J Haematol	2010	149(4):587-97
Wu L, Li X, Su J, Chang C, He Q, Zhang X, Xu L, Song L, Pu Q.	Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome.	Leuk Lymphoma	2009	50(9):1461-7

以上老師的信息來源于學(xué)校網(wǎng)站，如有更新或錯誤，請聯(lián)系我們進(jìn)行更新或刪除，聯(lián)系方式

添加上海交通大學(xué)學(xué)姐微信，或微信搜索公眾號“考研派小站”，關(guān)注[考研派小站]微信公眾號，在考研派小站微信號輸入[上海交通大學(xué)考研分?jǐn)?shù)線、上海交通大學(xué)報錄比、上海交通大學(xué)考研群、上海交通大學(xué)學(xué)姐微信、上海交通大學(xué)考研真題、上海交通大學(xué)專業(yè)目錄、上海交通大學(xué)排名、上海交通大學(xué)保研、上海交通大學(xué)公眾號、上海交通大學(xué)研究生招生）]即可在手機(jī)上查看相對應(yīng)上海交通大學(xué)考研信息或資源。

上海交通大學(xué)

本文來源：http://m.zhongzhouzhikong.com/shanghaijiaotongdaxue/daoshi_492567.html